Tracey Taveira, Pharm.D., CDOE

  • Professor
  • Office: 244K
  • Phone: 401.273.7100 x6265
  • Email:
  • Office Location: Avedisian Hall, 7 Greenhouse Road, Kingston, RI 02881


Dr. Taveira is a Professor of Pharmacy at the University of Rhode Island and Adjunct Professor of Medicine at Brown University with a clinical and research appointment with the Department of Veterans Affairs Medical Center. Her expertise and program of scholarship focuses on pharmacist-led multidisciplinary interventions in the areas of diabetes, cardiovascular risk reduction and heart failure.  She has conducted and published several randomized controlled studies evaluating interventions for diabetes and cardiovascular risk reduction.  She was a member of the 2015 and 2016 American Diabetes Association Professional Practice Committee (PPC).  The PPC is responsible for writing the “Standards of Medical Care in Diabetes” position statement, referred to as the “ADA Standards of Care”.  Appointment to the PPC is based on excellence in clinical practice and/or research. Dr. Taveira was also the co-author for the 2016 American Diabetes Association Diabetes Management in Long-term Care and Skilled Nursing Facilities Position Statement. She is also a current member of the American Diabetes Scientific and Medical Programs Oversight Committee.  Members of the Scientific and Medical Programs Oversight Committee play a major role in the development of the ADA’s strategic plan and in the development of strategies to advance the ADA’s mission.


Dr. Taveira’s program of scholarship focuses on interventions for the redesign of health care delivery for cardiovascular risk reduction in patients with diabetes and co-morbid mental health conditions.  Specifically, her research evaluates the efficacy of pharmacist-led shared medical appointments-SMAs (group visits in which several patients meet with an individual provider at the same time) for diabetes and cardiovascular risk reduction in patients with co-morbid mental health conditions by way of randomized controlled trials.  This work is important because cardiovascular disease is the leading cause of death in the United States and nearly 26 million persons in the United States have diabetes mellitus.  Since 65% of patients with diabetes die from cardiovascular disease, concomitant control of cardiovascular disease risk factors along with glycemic control is important to prevent chronic complications and adverse outcomes. However, chronic control of risk factors is difficult to accomplish in traditional care settings and the presence of a co-morbid mental health conditions makes risk factor control even more difficult to accomplish.

She has published manuscripts on the effectiveness of this model for patients with co-morbid mental health conditions and have received The Health Outcomes Research Award from the American College of Clinical Pharmacy and The American Heart Association Clinical Scientist Award in 2012 to evaluate the addition of behavioral activation therapy to our pharmacist-led SMA program for diabetes and depression. In 2012 the Department of Veterans Affairs Health Services Research and Development Service conducted a systematic review to determine whether SMAs compared with usual care improved; patient care, treatment adherence, health care cost and biophysical markers such as hemoglobin A1c and blood pressure . Her work served as a large component of the data (see Taveira et al 2010; Taveira et al 2011; Cohen, Taveira, 2011) to support the implementation of SMAs nationwide


Pharmacy Practice Residency, University of Rhode Island, 2000–2001
Doctor of Pharmacy, University of Rhode Island, 2000


Selected Publications

Taveira TH, Wu WC, Martin OJ, Schleinitz MD, Friedman P, Sharma SC. Pharmacist-led cardiac risk reduction model. Prev Cardiol 2006; 9(4):202-8.

Martin OJ, Wu WC, Taveira TH, Eaton CB, Sharma SC. Multidisciplinary group behavioral and pharmacologic intervention for cardiac risk reduction in diabetes – A Pilot Study.  Diabetes Educ 2007; 33(1):1118-27.

Pirraglia PA, Taveira TH, Cohen LB, Wu W. Effectiveness of a multifactorial cardiovascular risk reduction clinic for diabetes patients with depression. Prev Chronic Dis 2008; Oct:5(4):A1-7.

Khatana SM, Taveira TH, Miner MM, Eaton CB, Wu WC. Does cardiovascular risk reduction alleviate erectile dysfunction in men with type 2 diabetes mellitus? Int J Impot Res 2008; Sep-Oct;20(5):501-6.

Taveira TH, Pirraglia PA, Cohen LB, Wu WC. Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions. Prev Cardiol 2008;11(4):195-200.

Pirraglia PA, Taveira TH, Cohen LB, Dooley AG, Wu WC. Maintenance of cardiovascular risk goals in veterans with diabetes after discharge from a cardiovascular risk reduction clinic. Prev Cardiol 2009;12(1):3-8.

Khatana SA, Taveira TH, Choudhary G, Eaton CB, Wu WC. Change in hemoglobin A1C and C-reactive protein levels in patients with diabetes mellitus. J Cardiometab Synd 2009;4:1-5.

Taveira TH, Friedmann PD, Cohen LB, Dooley AG, Khatana SA, Pirraglia PA, Wu WC. Pharmacist-led group medical appointment model type 2 diabetes. Diabetes Educ 2010;36(1):109-17.

Jankowich MD, Taveira TH, Wu, WC. Decreased lung function is associated with increased arterial stiffness as measured by peripheral pulse pressure: Data from NHANES III.  Am J Hypertens 2010;23(6):614-9.

Khatana SA, Taveira TH, Wu WC. The association between C-reactive protein levels and insulin therapy in obese vs. non-obese veterans with type 2 diabetes mellitus. J Clin Hypertens 2010;12(6):462-8.

Cohen LB, Pirraglia PA, Taveira TH, Wu WC. Maintenance of risk factor control in patients with diabetes after discharge from a cardiovascular risk reduction clinic in patients with and without mental health conditions. Ann Pharmacother 2010; 44(7-8):1164-1170.

Khatana SA, Kane J, Taveira TH, Bauer MS, Wu WC.  Monitoring and prevalence rates of metabolic syndrome in veterans with major mental illness. PloS One 2011;6(4): e19298. doi:10.1371/journal.pone.0019298

Jankowich MD, Choudhary G. Taveira TH, Wu WC. Age, race, and gender-specific prevalence of diabetes among smokers. Diabetes Res Clin Pract 2011; Sep;93(3):e101-5. Epub 2011 Jun 16.

Cohen LB, Taveira TH, Khatana SA, Dooley AG, Pirraglia PA, Wu WC. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ 2011 Nov;37(6):801-12. Epub 2011 Oct 21.

Taveira TH, Dooley AG, Cohen LB,  Khatana SA,Wu WC. Pharmacist-led group medical appointments for the management of type 2 diabetes with co-morbid depression in older adults. Ann Pharmacother 2011 Nov;45(11):1346-55. Epub 2011 Oct 25.

Malandrino N, Wu WC, Taveira TH, Whitlatch HB, Smith RJ. Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Diabetologia 2012 Jan;55(1):226-35. Epub 2011 Oct 15.

Pirraglia PA, Rowland E, Wu WC, Friedmann PD, O’Toole TP, Cohen LB, Taveira TH. The benefits of a primary care clinic co-located and integrated in the mental health setting for veterans with serious mental illness. Prev Chronic Dis. 2012 Feb;9:E51. Epub 2012 Feb 2.

Charpentier MM, Orr KK. Taveira TH. Improving pharmacist knowledge of oral chemotherapy in the community.  Ann Pharmacother 2012;46(9):1205-11. doi: 10.1345/aph.1R056. Epub 2012 Aug 28.

Patel N, Taveira TH, Choudhary C, Wu WC. C-peptide levels predict cardiovascular and diabetes related mortality in nondiabetic adults.  J Am Heart Assoc 2012 Dec;1(6):e003152. doi: 10.1161/JAHA.112.003152. Epub 2012 Dec 19.

Bharath S, Davis R, Taveira TH, Wu WC. Association between intensity of perioperative glycemic control and postoperative outcomes in the patient with diabetes: A meta-analysis. Diabetes Res Clin Pract 2013;102(1):8 15. doi: 10.1016/j.diabres.2013.05.003. Epub 2013 Jun 6.

Taveira TH, Wu WC, Tschibelu E, Borsook D, Simonson D, Yamamoto R, Langleben DD, Swift R, Elman I. The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled study. J Psychopharm 2014;28(4):395-400. Doi 10.1177/0269881113509904

Taveira TH, Wu WC.   Interventions to maintain cardiac risk control after discharged from a cardiovascular risk reduction clinic: A randomized controlled trial. Diabetes Res Clin Pract 2014 Jun 10. pii: S0168-8227(14)00267-8. doi: 10.1016/j.diabres.2014.05.013.

 American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2015 38(S1):S1-S94.

 American Diabetes Association. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2016 39(S1): S1-S112.

Munshi MN, Florez H, Huang ES, Kalvani RR, Mupanomunda M, Pandva N, Swift CS, Taveira TH, Haas LB. Management of diabetes in long-term care and skilled nursing facilities: A position statement of the American Diabetes Association. Diabetes Care 2016;39(2):308-18. doe: 10.2337/dc15-2512.

Taveira TH.  Ouellette D, Gulum A, Choudhary G, Eaton CB, Liu S, Wu WC.  Relation of Magnesium Intake with Cardiac Function and Heart Failure Hospitalizations in Black Adults: The Jackson Heart Study. Circ Heart Fail. 2016 Apr;9(4). pii e002698. doi: 101161/circheartfailure.115.002698.

Tokuda L, Lorenzoa L, Theriault A, Taveira TH, Marquis L, Head H, Edelman D, Kirsh SR. Aron DC, Wu WC.  The utilization of video-conference shared medical appointments in rural diabetes care.  Int J Med Inform 2016; 93:34-41.

Cohen LB, Parent M, Taveira TH, Dev S, Wu WC. A description of patient and provider experiences and clinical outcomes after heart failure shared medical appointments. J Patient Experience 2017. Article first published online: June 2017 DOI:

Wu, WC, Taveira TH, Jeffery S, Jiang L, Tokuda L, Musial J, Cohen, LB, Uhrle F. Cost and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial.  PLOS ONE 2018; 13(4). e0195898. doi: 10.1371/journal.pone.0195898.

Malandrino N, Capristo1 E, Taveira TH, Mingrone G, W.C. Wu.  Cognitive function in individuals with normal weight obesity: results from the Third National Health and Nutrition Examination Survey (NHANES III).  J Alzheimer’s Dis 2018;65(1):125-135. doi: 10.3233/JAD-180264.

Wu WC, Parent M, Dev S, Hearns R, Taveira TH, Cohen L, Shell-Boyd J, Jewett-Tennant J, Marshall V, Gee J, Shaub K, LaForest S, Ball S. Group medical visits after heart failure hospitalization: Study protocol for a randomized-controlled trial.  Contemp Clin Trials 2018;71:140-45.doi:10.1016/j.cct.2018.06.015